Brigid L. Vaughan
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Brigid L. Vaughan.
Pediatric Clinics of North America | 2002
Sharon Levy; Brigid L. Vaughan; John R Knight
Because substance use is highly prevalent among teens, primary care clinicians may not be able to refer all adolescents to drug counselors or mental health care professionals. Pediatricians may therefore find it useful to use the basic principles of office intervention and reserve referral for those patients with the most significant drug and alcohol problems. Brief interventions have proven effective in reducing problematic drinking among adults, and early work among adolescents is promising. Effective interventions include feedback on risks and problems, an emphasis on personal responsibility, a menu of alternatives for change, an empathetic approach, and reinforcement of patient self-efficacy. Motivational interviewing is an effective means of enhancing success in counseling. When a referral is necessary, motivational interviewing can be used to maximize adherence.
Pediatric Emergency Care | 2005
Pamela J. Burke; Joanne O'Sullivan; Brigid L. Vaughan
Abstract: Use of tobacco, alcohol and other drugs plays a major role in adolescent morbidity and mortality. When under the influence of alcohol or other drugs, adolescents are at increased risk for injuries, unprotected sex, or interpersonal violence. Alcohol and other drugs are major factors in adolescent deaths, contributing to motor vehicle crashes, homicides, and suicides. Adolescents tend to have shorter substance use histories therefore they often experience emergency/acute care health treatment resulting from substance use related trauma and/or overdose. Substance use screening of adolescents who present to an Emergency Department (ED) is vitally important. The CRAFFT is a valid and reliable screening tool that was developed for use with adolescents. If an adolescent screens positive, then the next step is to determine their stage of use and readiness for change in preparation for doing a brief intervention. Helping patients to recognize the potential relation between their substance use and health related consequences, may motivate them to decrease their use for harm reduction. Motivational interviewing is an effective, evidence-based approach to helping people change their high risk behavior.
Pediatrics | 2007
Lon Sherritt; Brigid L. Vaughan; Matthew Germak; John R Knight
OBJECTIVE. The objective of this study was to estimate from a random urine drug-testing program for adolescents the proportion of drug tests that are susceptible to interpretation errors. METHODS. This was a secondary analysis of a clinical database and chart review from an adolescent outpatient substance abuse program at a large childrens hospital. We analyzed from 110 adolescent patients (13–21 years of age) all 710 urine drug test results that were collected between December 2002 and July 2005 and 85 original laboratory reports for tests that were collected between December 2002 and May 2006 and were confirmed positive for opioids. We calculated the percentage of tests that were too dilute to interpret (potential false-negatives) and the percentage of confirmed positive tests for oxycodone that did not result in a positive initial screen (potential false-negatives). We also reviewed clinical information to determine whether confirmed positive tests resulted from legitimate use of prescription or over-the-counter medication (potential false-positives). RESULTS. Of 710 drug tests, 40 negative tests were too dilute to interpret properly, and 45 of 217 positive tests resulted from prescription medication use for a total of 85 tests that were susceptible to error. Of the 85 confirmatory laboratory reports reviewed, 43 were positive for oxycodone, but only 16 of these had produced a positive opiate screen. CONCLUSIONS. Unless proper procedures are used in collecting, analyzing, and interpreting laboratory testing for drugs, there is a substantial risk for error.
Journal of Child and Adolescent Psychopharmacology | 2007
Marcia L. Zuckerman; Brigid L. Vaughan; Jane Whitney; Alice Dodds; Aleksandra Yakhkind; Carlene MacMillan; Darcy Raches; Iva Pravdova; David R. DeMaso; William R. Beardslee; Joseph Gonzalez-Heydrich
Psychosomatics | 2000
David R. DeMaso; Eve Garlington Spratt; Brigid L. Vaughan; Eugene J. D’Angelo; Julie Van der Feen; Edward P. Walsh
Journal of Adolescent Health | 2007
Sharon Levy; Brigid L. Vaughan; Michelle Angulo; John R Knight
General Hospital Psychiatry | 2002
Stuart L. Lustig; Christine Botelho; Linda Lynch; Sally V Nelson; William J Eichelberger; Brigid L. Vaughan
Substance Abuse | 2006
Pamela J. Burke; John D. Da Silva; Brigid L. Vaughan; John R Knight
Archive | 2003
Brigid L. Vaughan; Sharon Levy; John R Knight
Harvard Review of Psychiatry | 2001
Christopher J. Lukonis; Stuart L. Lustig; Renée Brant; Stuart J. Goldman; Brigid L. Vaughan